Nirvana Life Sciences Inc. (CSE: NIRV)

Canada flag Canada · Delayed Price · Currency is CAD
0.0750
0.00 (0.00%)
Sep 25, 2024, 4:00 PM EDT
87.50%
Market Cap 3.62M
Revenue (ttm) n/a
Net Income (ttm) -1.23M
Shares Out 48.23M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 36,000
Open 0.0750
Previous Close 0.0750
Day's Range 0.0750 - 0.0750
52-Week Range 0.0100 - 0.1150
Beta 0.68
Analysts n/a
Price Target n/a
Earnings Date Aug 29, 2024

About Nirvana Life Sciences

Nirvana Life Sciences Inc. engages in the scientific research and development of therapeutic products derived from psychedelics. It also focuses on developing methodologies for extraction and purification of psychoactive compounds. The company is headquartered in Vancouver, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Bruce Clark
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol NIRV
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.